Torhild Garen

  • Coordinateur, NOSVAR
  • +47 23 07 39 01
Research topics ; clinical epidemiology
 

Publications 2021

Didriksen H, Molberg O, Fretheim H, Gude E, Jordan S, Brunborg C, Palchevskiy V, Garen T, Midtvedt O, Andreassen AK, Distler O, Belperio J, Hoffmann-Vold AM (2021)
Association of Lymphangiogenic Factors With Pulmonary Arterial Hypertension in Systemic Sclerosis
Arthritis Rheumatol., 73 (7), 1277-1287
DOI 10.1002/art.41665

Publications 2020

Fretheim H, Chung BK, Didriksen H, Baekkevold ES, Midtvedt O, Brunborg C, Holm K, Valeur J, Tennoe AH, Garen T, Midtvedt T, Troseid M, Zare H, Lund MB, Hov JR, Lundin KEA, Molberg O, Hoffmann-Vold AM (2020)
Fecal microbiota transplantation in systemic sclerosis: A double-blind, placebo-controlled randomized pilot trial
PLoS One, 15 (5), e0232739
DOI 10.1371/journal.pone.0232739

Fretheim H, Halse AK, Seip M, Bitter H, Wallenius M, Garen T, Salberg A, Brunborg C, Midtvedt O, Molberg O, Hoffmann-Vold AM (2020)
Multidimensional tracking of phenotypes and organ involvement in a complete nationwide systemic sclerosis cohort
RHEUMATOLOGY, 59 (10), 2920-2929
DOI 10.1093/rheumatology/keaa026

Tashbayev B, Garen T, Palm O, Chen X, Herlofson BB, Young A, Hove LH, Rykke M, Singh PB, Aqrawi LA, Utheim OA, Utheim TP, Jensen JL (2020)
Patients with non-Sjogren's sicca report poorer general and oral health-related quality of life than patients with Sjogren's syndrome: a cross-sectional study
Sci Rep, 10 (1), 2063
DOI 10.1038/s41598-020-59078-0

Publications 2019

Elhai M, Boubaya M, Distler O, Smith V, Matucci-Cerinic M, Sancho JJ, Truchetet ME, Braun-Moscovici Y, Iannone F, Novikov PI, Lescoat A, Siegert E, Castellvi I, Airo P, Vettori S, Langhe E, Hachulla E, Erler A, Ananieva L, Krusche M, Lopez-Longo FJ, Distler JHW, Hunzelmann N, Hoffmann-Vold AM, Riccieri V et al. (2019)
Outcomes of patients with systemic sclerosis treated with rituximab in contemporary practice: a prospective cohort study
Ann. Rheum. Dis., 78 (7), 979-987
DOI 10.1136/annrheumdis-2018-214816

Elhai M, Hoffmann-Vold AM, Avouac J, Pezet S, Cauvet A, Leblond A, Fretheim H, Garen T, Kuwana M, Molberg O, Allanore Y (2019)
Performance of Candidate Serum Biomarkers for Systemic Sclerosis-Associated Interstitial Lung Disease
Arthritis Rheumatol., 71 (6), 972-982
DOI 10.1002/art.40815

Garen T, Lerang K, Hoffmann-Vold AM, Andersson H, Midtvedt O, Brunborg C, Kilian K, Gudbrandsson B, Gunnarsson R, Norby G, Chaudhary A, Thoen J, Forseth KO, Fresjar K, Forre O, Haugen M, Haga HJ, Gran JT, Gilboe IM, Molberg O, Palm O (2019)
Mortality and causes of death across the systemic connective tissue diseases and the primary systemic vasculitides
RHEUMATOLOGY, 58 (2), 313-320
DOI 10.1093/rheumatology/key285

Hoffmann-Vold AM, Fretheim H, Halse AK, Seip M, Bitter H, Wallenius M, Garen T, Salberg A, Brunborg C, Midtvedt O, Lund MB, Aalokken TM, Molberg O (2019)
Tracking Impact of Interstitial Lung Disease in Systemic Sclerosis in a Complete Nationwide Cohort
Am. J. Respir. Crit. Care Med., 200 (10), 1258-1266
DOI 10.1164/rccm.201903-0486OC

Sobanski V, Giovannelli J, Allanore Y, Riemekasten G, Air P, Vettori S, Cozzi F, Distler O, Matucci-Cerinic M, Denton C, Launay D, Hachulla E, Cerinic MM, Guiducci S, Walker U, Kyburz D, Lapadula G, Iannone F, Distler O, Maurer B, Jordan S, Becvar R, Sierakowsky S, Bielecka OK, Cutolo M et al. (2019)
Phenotypes Determined by Cluster Analysis and Their Survival in the Prospective European Scleroderma Trials and Research Cohort of Patients With Systemic Sclerosis
Arthritis Rheumatol., 71 (9), 1553-1570
DOI 10.1002/art.40906

Publications 2018

Hoffmann-Vold AM, Fretheim H, Midtvedt O, Kilian K, Angelshaug M, Chaudhary A, Gunnarsson R, Brunborg C, Garen T, Andreassen AK, Gude E, Molberg O (2018)
Frequencies of borderline pulmonary hypertension before and after the DETECT algorithm: results from a prospective systemic sclerosis cohort
RHEUMATOLOGY, 57 (3), 480-487
DOI 10.1093/rheumatology/kex435

Hoffmann-Vold AM, Hesselstrand R, Fretheim H, Ueland T, Andreassen AK, Brunborg C, Palchevskiy V, Midtvedt O, Garen T, Aukrust P, Belperio JA, Molberg O (2018)
CCL21 as a Potential Serum Biomarker for Pulmonary Arterial Hypertension in Systemic Sclerosis
Arthritis Rheumatol., 70 (10), 1644-1653
DOI 10.1002/art.40534

Hoffmann-Vold AM, Weigt SS, Palchevskiy V, Volkmann E, Saggar R, Li N, Midtvedt O, Lund MB, Garen T, Fishbein MC, Ardehali A, Ross DJ, Ueland T, Aukrust P, Lynch JP, Elashoff RM, Molberg O, Belperio JA (2018)
Augmented concentrations of CX(3)CL1 are associated with interstitial lung disease in systemic sclerosis
PLoS One, 13 (11), e0206545
DOI 10.1371/journal.pone.0206545

Tennoe AH, Murbraech K, Andreassen JC, Fretheim H, Garen T, Gude E, Andreassen A, Aakhus S, Molberg O, Hoffmann-Vold AM (2018)
Left Ventricular Diastolic Dysfunction Predicts Mortality in Patients With Systemic Sclerosis
J. Am. Coll. Cardiol., 72 (15), 1804-1813
DOI 10.1016/j.jacc.2018.07.068

Publications 2017

Andersson H, Kirkhus E, Garen T, Walle-Hansen R, Merckoll E, Molberg O (2017)
Comparative analyses of muscle MRI and muscular function in anti-synthetase syndrome patients and matched controls: a cross-sectional study
Arthritis Res. Ther., 19, 17
DOI 10.1186/s13075-017-1219-y

Gudbrandsson B, Molberg O, Garen T, Palm O (2017)
Prevalence, Incidence, and Disease Characteristics of Takayasu Arteritis by Ethnic Background: Data From a Large, Population-Based Cohort Resident in Southern Norway
Arthritis Care Res., 69 (2), 278-285
DOI 10.1002/acr.22931

Gudbrandsson B, Wallenius M, Garen T, Henriksen T, Molberg O, Palm O (2017)
Takayasu Arteritis and Pregnancy: A Population-Based Study on Outcomes and Mother/Child-Related Concerns
Arthritis Care Res., 69 (9), 1384-1390
DOI 10.1002/acr.23146

Hoffmann-Vold AM, Midtvedt O, Tennoe AH, Garen T, Lund MB, Aalokken TM, Andreassen AK, Elhage F, Brunborg C, Taraldsrud E, Molberg O (2017)
Cardiopulmonary Disease Development in Anti-RNA Polymerase III-positive Systemic Sclerosis: Comparative Analyses from an Unselected, Prospective Patient Cohort
J. Rheumatol., 44 (4), 459-465
DOI 10.3899/jrheum.160867

Publications 2016

Andersson H, Aalokken TM, Gunther A, Mynarek GK, Garen T, Lund MB, Molberg O (2016)
Pulmonary Involvement in the Antisynthetase Syndrome: A Comparative Cross-sectional Study
J. Rheumatol., 43 (6), 1107-1113
DOI 10.3899/jrheum.151067

Gunnarsson R, El-Hage F, Aalokken TM, Reiseter S, Lund MB, Garen T, Molberg O, Norwegian MCTD Study Grp (2016)
Associations between anti-Ro52 antibodies and lung fibrosis in mixed connective tissue disease
RHEUMATOLOGY, 55 (1), 103-108
DOI 10.1093/rheumatology/kev300

Hoffmann-Vold AM, Tennoe AH, Garen T, Midtvedt O, Abraityte A, Aalokken TM, Lund MB, Brunborg C, Aukrust P, Ueland T, Molberg O (2016)
High Level of Chemokine CCL18 Is Associated With Pulmonary Function Deterioration, Lung Fibrosis Progression, and Reduced Survival in Systemic Sclerosis
Chest, 150 (2), 299-306
DOI 10.1016/j.chest.2016.03.004

Palm O, Ueland T, Garen T, Michelsen AE, Reiseter S, Aukrust P, Aalokken TM, Molberg O (2016)
Endostatin is higher and associated with pulmonary involvement in primary Sjogren's syndrome
Clin. Exp. Rheumatol., 34 (4), 690-693

Publications 2015

Andersson H, Sem M, Lund MB, Aalokken TM, Gunther A, Walle-Hansen R, Garen T, Molberg O (2015)
Long-term experience with rituximab in anti-synthetase syndrome-related interstitial lung disease
RHEUMATOLOGY, 54 (8), 1420-1428
DOI 10.1093/rheumatology/kev004

Dobloug C, Garen T, Bitter H, Stjarne J, Stenseth G, Grovle L, Sem M, Gran JT, Molberg O (2015)
Prevalence and clinical characteristics of adult polymyositis and dermatomyositis; data from a large and unselected Norwegian cohort
Ann. Rheum. Dis., 74 (8), 1551-1556
DOI 10.1136/annrheumdis-2013-205127

Dobloug GC, Antal EA, Sveberg L, Garen T, Bitter H, Stjarne J, Grovle L, Gran JT, Molberg O (2015)
High prevalence of inclusion body myositis in Norway; a population-based clinical epidemiology study
Eur. J. Neurol., 22 (4), 672-E41
DOI 10.1111/ene.12627

Dobloug GC, Garen T, Brunborg C, Gran JT, Molberg O (2015)
Survival and cancer risk in an unselected and complete Norwegian idiopathic inflammatory myopathy cohort
Semin. Arthritis Rheum., 45 (3), 301-308
DOI 10.1016/j.semarthrit.2015.06.005

Flam ST, Gunnarsson R, Garen T, Lie BA, Molberg O, Norwegian MCTD Study Grp (2015)
The HLA profiles of mixed connective tissue disease differ distinctly from the profiles of clinically related connective tissue diseases
RHEUMATOLOGY, 54 (3), 528-535
DOI 10.1093/rheumatology/keu310

Hoffmann-Vold AM, Gunnarsson R, Garen T, Midtvedt O, Molberg O (2015)
Performance of the 2013 American College of Rheumatology/European League Against Rheumatism Classification Criteria for Systemic Sclerosis (SSc) in Large, Well-defined Cohorts of SSc and Mixed Connective Tissue Disease
J. Rheumatol., 42 (1), 60-63
DOI 10.3899/jrheum.140047

Hoffmann-Vold AM, Aalokken TM, Lund MB, Garen T, Midtvedt O, Brunborg C, Gran JT, Molberg O (2015)
Predictive Value of Serial High-Resolution Computed Tomography Analyses and Concurrent Lung Function Tests in Systemic Sclerosis
Arthritis Rheumatol., 67 (8), 2205-2212
DOI 10.1002/art.39166

Ingegnoli F, Boracchi P, Gualtierotti R, Smith V, Cutolo M, Foeldvari I, Airo P, Alegre-Sancho JJ, Allanore Y, Ananieva LP, Ancuta C, Andrade LE, Aringer M, Becvar R, Bojinca M, Butrimiene I, Cantatore FP, Caporali R, Caramaschi P, Carreira PE, Chirieac R, Corrado A, Cosentino V, Cuomo G, Czirjak L et al. (2015)
A comparison between nailfold capillaroscopy patterns in adulthood in juvenile and adult-onset systemic sclerosis: A EUSTAR exploratory study
Microvasc. Res., 102, 19-24
DOI 10.1016/j.mvr.2015.07.007

Reiseter S, Molberg O, Gunnarsson R, Lund MB, Aalokken TM, Aukrust P, Ueland T, Garen T, Brunborg C, Michelsen A, Abraityte A, Hoffmann-Vold AM (2015)
Associations between circulating endostatin levels and vascular organ damage in systemic sclerosis and mixed connective tissue disease: an observational study
Arthritis Res. Ther., 17, 231
DOI 10.1186/s13075-015-0756-5

Publications 2014

Haugeberg G, Helgetveit KB, Forre O, Garen T, Sommerseth H, Proven A (2014)
Generalized bone loss in early rheumatoid arthritis patients followed for ten years in the biologic treatment era
BMC Musculoskelet. Disord., 15, 289
DOI 10.1186/1471-2474-15-289

Publications 2013

Gunnarsson R, Andreassen AK, Molberg O, Lexberg AS, Time K, Dhainaut ASS, Bertelsen LT, Palm O, Irgens K, Becker-Merok A, Nordeide JL, Johnsen V, Pedersen S, Proven A, Garabet LSN, Garen T, Aalokken TM, Gilboe IM, Gran JT (2013)
Prevalence of pulmonary hypertension in an unselected, mixed connective tissue disease cohort: results of a nationwide, Norwegian cross-sectional multicentre study and review of current literature
RHEUMATOLOGY, 52 (7), 1208-1213
DOI 10.1093/rheumatology/kes430

Hoffmann-Vold AM, Molberg O, Midtvedt O, Garen T, Gran JT (2013)
Survival and Causes of Death in an Unselected, and Complete Cohort of Norwegian Patients with Systemic Sclerosis
J. Rheumatol., 40 (7), 1127-1133
DOI 10.3899/jrheum.121390

Palm O, Garen T, Enger TB, Jensen JL, Lund MB, Aalokken TM, Gran JT (2013)
Clinical pulmonary involvement in primary Sjogren's syndrome: prevalence, quality of life and mortality-a retrospective study based on registry data
RHEUMATOLOGY, 52 (1), 173-179
DOI 10.1093/rheumatology/kes311

Publications 2012

Hoffmann-Vold AM, Midtvedt O, Molberg O, Garen T, Gran JT (2012)
Prevalence of systemic sclerosis in south-east Norway
RHEUMATOLOGY, 51 (9), 1600-1605
DOI 10.1093/rheumatology/kes076

Lerang K, Gilboe I, Garen T, Thelle DS, Gran JT (2012)
High incidence and prevalence of systemic lupus erythematosus in Norway
Lupus, 21 (12), 1362-1369
DOI 10.1177/0961203312458168

Publications 2011

Enger TB, Palm O, Garen T, Sandvik L, Jensen JL (2011)
Oral distress in primary Sjogren's syndrome: implications for health-related quality of life
Eur. J. Oral Sci., 119 (6), 474-480
DOI 10.1111/j.1600-0722.2011.00891.x

Strumse YAS, Nordvag BY, Stanghelle JK, Roisland M, Winther A, Pajunen PA, Garen T, Flato B (2011)
EFFICACY OF REHABILITATION FOR PATIENTS WITH ANKYLOSING SPONDYLITIS: COMPARISON OF A FOUR-WEEK REHABILITATION PROGRAMME IN A MEDITERRANEAN AND A NORWEGIAN SETTING
J. Rehabil. Med., 43 (6), 534-542
DOI 10.2340/16501977-0804

Publications 2009

Strumse YAS, Nordvag BY, Stanghelle JK, Roisland M, Winther A, Pajunen PA, Garen T, Flato B (2009)
The efficacy of rehabilitation for patients with rheumatoid arthritis: comparison between a 4-week rehabilitation programme in a warm and a cold climate
Scand. J. Rheumatol., 38 (1), PII 901897742-37
DOI 10.1080/03009740802304549